Actimus Bio
Generated 5/24/2026
Executive Summary
Actimus Bio, established in 2005 and headquartered in Visakhapatnam, India, is a contract research organization (CRO) providing end-to-end services for pharmaceutical and biotech companies. Its offerings span bioanalytical testing, bioavailability/bioequivalence (BA/BE) studies, biopharmaceutics, clinical trial management, medical writing, and statistical analysis. Leveraging FDA-approved, state-of-the-art facilities and a multidisciplinary team of 200–500 employees, Actimus supports drug development across multiple therapeutic areas. As a privately held platform company, Actimus does not develop its own drugs but rather enables sponsors to accelerate development timelines through reliable, cost-effective outsourcing solutions. The firm has built a reputation over two decades as a trusted partner in the global CRO market, particularly for sponsors seeking high quality at competitive rates from an established Asian provider.
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)